首页 > 中国癌症研究（英文版） > Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases

Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases

导出在线阅读解读下载全文终端阅读

二维码有效期 120s

点击刷新

注：终端设备浏览有效期：

学术成果认领

翻译打印收藏纠错

作者单位 NPO HIPEC ISTANBUL, Akkavak Sokak No: 4/2 Nisantasi, Istanbul 34365, Turkey;Ethica Incirli Hospital, Bakirkoy, Istanbul 34144, Turkey;NPO to support Peritoneal Dissemination Treatment , 1-26, Harukimotomachi, Kishiwada City, Osaka 596-8522, Japan ^[1] NPO HIPEC ISTANBUL, Akkavak Sokak No: 4/2 Nisantasi, Istanbul 34365, Turkey;NPO to support Peritoneal Dissemination Treatment , 1-26, Harukimotomachi, Kishiwada City, Osaka 596-8522, Japan; Department of General Surgery, Kusatsu General Hospital, Yabase 1660, Kusatsu, Japan; Department of General Surgery, Kishiwada Tokushukai Hospital, 4-27-1 Kamori-Cho, Kishiwada City, Osaka 596-8522, Japan ^[2] Department of Peritoneal Surface Malignancy, Bon Secours Cancer Institute, Richmond VA 23226,USA ^[3] Deparment of General Surgery, Yonsei University College of Medicine, Seoul, South Korea ^[4] Center for Gastrointestinal Malignancies ,Program in Peritoneal Surface Oncology, MedStar Washington Hospital Center, NW, POB North Tower 3900 Washington, DC 20010, USA ^[5]

关键词 Gastric cancer (GC)peritoneal carcinomatosis intraperitoneal and systemic induction chemotherapy cytoreductive surgery (CRS)hyperthermic intraperitoneal chemotherapy (IPC)

栏目名称

Editorial

DOI 10.3978/j.issn.1000-9604.2014.02.06

发布时间 2014-05-12（万方平台首次上网日期，不代表论文的发表时间）

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交